5Li Destri G, Rinzivillo C, Craxi G, et al. Colorectal follow-up planning modifiedon the basis of our personal experience. Dig Surg,1998,15(1)∶64-68. 被引量：1
6Mansel JK, Zinsmeister AR, Pairolero PC, et al. Pulmonary resection of metastaticcolorectal adenocarcinoma. A ten year experience. Chest,1986,89(1)∶109-112. 被引量：1
7Goya T, Miyazawa N, Kondo H, et al. Surgical resection of pulmonary metastases fromcolorectal cancer. 10-year follow-up. Cancer,1989,64(7)∶1418-1421. 被引量：1
7Tezuka M,Hayashi K,Kubota K,et al.Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization:comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma[J].Dig Dis Sci,2007,52(3):783. 被引量：1
8Low SC,Lo RH,Lau TN,et al.Image-guided radiofrequency ablation of liver malignancies:experience at Singapore General Hospital[J].Ann Acad Med Singapor,2006,35(12):851. 被引量：1
9Vogl TJ,Zangos S,Eichler K,et al.Colorectal liver metastases:regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion:an update[J].Eur Radiol,2007,17(4):1025. 被引量：1
10Georgiades CS,Liapi E,Frangakis C,et al.Prognostic accuracy of 12 liver staging systems in patients with unresectable hepatocellular carcinoma treated with transarterial chemoembolization[J].J Vasc Interv Radiol,2006,17(10):1619. 被引量：1
